|
|
||||||||||||||||||||||||||||||||||||||
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 99
-->
Appendix B
Acronyms
BSL-4:
Biological Safety Level 4
CDC:
Centers for Disease Control and Prevention, Atlanta, Ga.
CMV:
Cytomegalovirus
COI:
World Health Organization Committee on Orthopox Infections
DHHS:
U.S. Department of Health and Human Services
DOD:
U.S. Department of Defense
DOE:
U.S. Department of Energy
EEV:
Extracellular Enveloped Virus
FDA:
U.S. Federal Drug Administration
HA:
Hemagglutinin antigen
HEPA (filters):
High-efficiency particulate air (filters)
HI:
Hemagglutinin-inhibiting
HIV:
Human immunodeficiency virus.
HPMPA:
((S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine)
IMV:
Intracellular Mature Virus
IND:
Investigational new drug
JCG:
Joint coordinating group
NIH:
National Institutes of Health
NYCBH:
New York City Board of Health
PCR:
Polymerase chain reaction.
PMEA:
Adefovir, 9-[2-(phosphonomethoxy)ethyl]adenine)
RLFP:
Restriction fragment length
UDG:
Uracil DNA glycosylase
USAMRIID:
U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick., Md.
OCR for page 100
-->
VECTOR:
State Center of Virology and Biotechnology, Koltsovo, Russia
VIG:
Vaccinia Immune globulin
WHA:
World Health Assembly
WHO:
World Health Organization
Representative terms from entire chapter:
enveloped virus